September 2023 - New Article!

Our latest research on ‘Polymer-Lipid Hybrid Nanoparticles as Potential Lipophilic Anticancer Drug Carriers’ has just been published in Discover Nano. 

In this work, we have produced hybrid nanoparticles made of fully natural materials without requiring any toxic stabilizers to use them as enzyme-responsive drug carriers. Some important achievements of this 'in-house nanoparticles' include enhanced biocompatibility, stability, green production approach and controlled drug delivery. Have a look if you are interested in!